A recent study analyzed data from community health centers in the US between 2012-2020, finding that U.S.-born Latinos have significantly higher obesity rates compared to foreign-born Latino and non-Hispanic White youth. The researchers noted a trend of increasing obesity prevalence over time across all three groups.
The conference will feature keynote speakers Donna Ryan and Erik Wilson, as well as informative presentations and breakout sessions on the latest advances in obesity research. The Louisiana Obesity Society aims to support healthcare providers treating obesity through education and networking.
The Obesity Society has appointed a new CEO, Sherlyn Celone-Arnold, and several key experts to its leadership team, enhancing its commitment to addressing obesity through innovative strategies and expert guidance.
A new genetic analysis has created a polygenic risk score (PGS) that reliably associates with adulthood obesity, showing consistent patterns in early childhood. This measure could help identify children and adolescents at higher genetic risk of developing obesity later in life, benefiting from targeted preventative strategies.
A new genetic test can predict adulthood obesity in early childhood, allowing for targeted preventative strategies. The test was developed using data from over five million people and found to be twice as effective as previous tests at predicting obesity risk.
A new study found that anti-obesity medications can normalize testosterone levels in men with obesity or type 2 diabetes. This positive effect on reproductive health was observed after a 10% weight loss, with total and free testosterone levels increasing by 24%.
Cancer deaths linked to obesity have increased sharply in the US, especially among women and older adults, with sharp regional disparities. The study highlights the need for targeted public health strategies to address this growing public health crisis.
Researchers found that tirzepatide reduced body weight and body fat by approximately 20% in mice, resulting in a significant reduction of tumor volume. The study suggests that this new anti-obesity drug may have a beneficial impact on breast cancer outcomes.
The AMA has passed a resolution calling for easier access to anti-obesity medications, which have been shown to help adults lose an average of 15-20% of their weight. Improved access could benefit millions nationwide, reducing obesity-related medical costs estimated at $173 billion annually.
The Endocrine Society supports the bipartisan legislation to ensure people living with obesity have access to effective treatments. The bill will cover anti-obesity medications and intensive behavioral therapy, addressing the chronic disease's complications like cancer, type 2 diabetes, and heart disease.
Researchers found that obese mice displayed more anxiety-like behaviors and showed different signaling patterns in the hypothalamus, a region involved in regulating metabolism. The study also observed distinct differences in the makeup of gut bacteria in obese mice compared to lean mice.
A new analysis of over 18,000 cancer cases suggests that obese patients may fare better after immunotherapy treatment, with improved overall survival rates. The study's findings raise intriguing questions about the role of obesity in immunotherapy effectiveness and highlight the need for further research to understand this phenomenon.
Bariatric surgery, a critical tool for combating obesity, is under threat in Australia due to skyrocketing indemnity insurance premiums. The study found that surgeons are being penalized by rising premiums, forcing some to reconsider their future in the field.
A study found that impulsivity in ADHD is linked to reduced physical activity, which can contribute to obesity. Urban lifestyle factors like food insecurity and access to mental health care influence this relationship.
Research reveals rural preschoolers spend more time on screens and engage in less physical activity than their urban counterparts. The study found 24% of rural children have overweight or obesity, compared to 16% in urban areas.
A global survey found a significant disconnect between physicians' and patients' perceptions of obesity causes and treatment goals. Physicians tend to attribute obesity to behavioral causes, while patients cite biological factors as the primary cause.
A new study published at the European Congress on Obesity suggests that GLP-1 agonist drugs can lead to a clinically relevant change in BMI for children with severe obesity. In this study, 30% of children who received GLP-1 drugs experienced a significant reduction in BMI, compared to around 27% of those who did not receive them.
A new head-to-head study has shown that tirzepatide results in around 50% more weight loss than semaglutide in adults with obesity. The study found that tirzepatide led to an average weight loss of 20.2%, significantly higher than the 13.7% achieved with semaglutide.
Researchers found that GLP-1 receptor agonists have a direct effect on reducing obesity-related cancer beyond weight-loss, with a 41% lower relative risk compared to bariatric surgery. The study also suggests that these medications work through multiple mechanisms, including reducing inflammation.
A child's body mass index (BMI) at six years old is a strong predictor of their risk of overweight or obesity at 18. Reaching a healthier weight before six can reduce this risk, but returning to it later does not have the same effect.
A Swedish study found that individuals who lived with obesity as children are four times more likely to be on sick leave aged 25 than their peers in the general population. The study also revealed that those with severe childhood obesity were three times more likely to be on long-term sick leave.
A Danish study found that adverse waist-to-height ratio trajectories in childhood are associated with increased cardiometabolic risk at age 10. Children with gradually increasing central obesity showed early signs of metabolic and cardiovascular risk, including elevated blood pressure and insulin resistance.
A US study found that teenagers with abdominal obesity have larger brain areas, particularly in the hippocampus and amygdala, which play critical roles in memory, learning, and emotion regulation. This research raises serious concerns about the impact of obesity on brain development and long-term health risks.
A new Australian study highlights the need to support women and their families with overweight or obesity before pregnancy. The research found that a woman's BMI in early pregnancy is linked to her child's weight from birth to age 10, with every 5kg/m² increase in maternal BMI associated with an increase in child BMI.
A recent study highlights the alarming rise in cardiovascular deaths for those with obesity, disproportionately impacting minorities and women. Contrary to common perception, patients with obesity and critical limb ischemia experience significantly improved survival rates compared to non-obese patients.
A recent study published in The Lancet: Diabetes & Endocrinology reveals a significant increase in obesity rates among US adults, particularly those with BMI above 60 kg/m2. The rate of severe obesity rose by 210% over 20 years, posing serious health risks and economic burdens.
A new study identifies that the internationally recognized body mass index (BMI) cut-off points overestimate overweight and obesity in male athletes. The researchers propose new cut-off points of 28.2 kg/m² for overweight and 33.7 kg/m² for obesity, taking into account lower body fat percentages typical of athletes.
The 2025 Bray Obesity Symposium provides valuable insights and guidance from leading researchers in obesity medicine. The symposium features topics such as advances in obesity genetics, pediatric obesity, lifestyle intervention, and pharmacotherapy.
Research found a significant increase in the prevalence of overweight and obesity among English adolescents, from 22% to 33% between 2008-2010 and 2021-2023. Adolescents living with these conditions are at higher risk for developing comorbidities, including mental health issues, physical problems, and cardiometabolic diseases.
A new study found that tirzepatide can produce sustained weight loss of up to 31% in adults with overweight or obesity without diabetes, regardless of age or BMI. The study also identified patterns of weight loss trajectories and found that females and those without obesity-related complications may be more responsive to the medication.
A new study found that both employed people with obesity and employer representatives acknowledge the impact of obesity on future health problems and perceive lifestyle change alongside anti-obesity medications as the most effective approach for maintaining weight-loss reduction. Cost of medication coverage remains a significant barrie...
A comprehensive longitudinal analysis of obesity trajectories identified distinct patterns affecting brain morphology, function, and cognition in middle-aged and older adults. The study suggests sustained obesity accelerates brain aging, highlighting the clinical importance of long-term monitoring and management.
A six-month study found that patients using GLP-1 and dual GLP-1/GIP receptor agonist therapy experienced minimal lean muscle mass loss as they lost weight. Regular resistance training, consistent protein intake, and close supervision by an expert obesity doctor were associated with better muscle retention.
The Endocrine Society strongly disagrees with the administration's decision not to finalize a rule allowing Medicare and Medicaid to cover anti-obesity medications. This decision leaves millions of Americans with obesity without access to evidence-based treatment, exacerbating the country's growing obesity epidemic.
The American College of Physicians has awarded $260,000 in grants to support regional programs addressing equity challenges in obesity care. Thirteen grantees will implement collaborative outreach projects to train medical professionals and their patients to combat misinformation and improve clinical capacity for obesity care.
A new review of studies on percentage weight-based targets in obesity interventions found that these targets often result in a 'success or failure' outcome, leaving little room for improvement in obesity-related complications, quality of life, and overall physical and social functioning. The study recommends shifting focus towards more...
A new white paper finds that expanding access to anti-obesity medications can prevent or delay chronic disease by years, providing significant societal benefits. The study estimates a $10 trillion return on investment and 13% annual returns on investment for society.
A new study found that high sodium intake is linked to a higher risk of both general and abdominal obesity in Finnish adults. The study showed that participants with high dietary sodium intake or high urine sodium concentration were more likely to have general or abdominal obesity.
A large majority of older Americans believe health insurance – including Medicare – should cover anti-obesity medications. Nearly 37% of respondents met the criteria for overweight and 36% for obesity. Medicare currently covers a drug used for weight management but only in people with diabetes or a history of heart attack or stroke.
Researchers found that dogs carrying the genetic variant DENND1B had higher body fat content, while humans also carry this gene linked to obesity. The study highlights the importance of fundamental brain pathways in regulating appetite and body weight.
A genome-wide association study of Labrador retrievers identified the DENND1B gene as a key factor in canine obesity, with strong genetic similarities to its human counterpart. The study highlights the value of using dogs as a model for studying human obesity and reveals potential targets for future research.
A major new analysis predicts that over half the world's adult population (3.8 billion) and a third of all children and adolescents (746 million) will be living with overweight or obesity by 2050. The study forecasts a substantial rise in obesity among young people globally, with an additional 186 million cases predicted by 2050.
The Childhood Obesity Prevention, Evaluation and Treatment Toolkit provides healthcare providers with practical guidance for preventing, evaluating, and treating childhood obesity. The toolkit is grounded in scientific evidence and offers actionable treatment approaches for children and adolescents dealing with overweight and obesity.
New guidelines from European Association for the Study of Obesity aim to improve patient safety in obesity surgery medical tourism. The guidelines recommend multiple aspects of care, including at least 2 years of follow-up and pre-operative alcohol screening, to prevent serious injuries and death.
A study published in JAMA Pediatrics found that childhood obesity treatment can reduce the risk of serious health problems such as type 2 diabetes, hypertension, and dyslipidaemia in young adults. However, it did not have a lasting impact on depression and anxiety, which remained unchanged regardless of treatment outcomes.
The Lancet Commission on Clinical Obesity proposes a new model for diagnosing clinical obesity based on objective measures of illness at the individual level. The proposal aims to settle the ongoing dispute around the idea of obesity as a disease, providing a medically coherent framework for diagnosis.
The global Commission recommends diagnosing obesity based on excess body fat measures and objective signs of illness, shifting from BMI-based definition. This approach aims to provide personalized care for individuals with clinical and pre-clinical obesity, facilitating fair allocation of healthcare resources.
Obesity increases cancer risk via chronic low-grade inflammation, hormonal disturbances, and gut microbiota dysregulation. Prevention strategies include weight management through diet and exercise, bariatric surgery, and pharmacotherapy.
A recent population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an elevated risk of dying. The study found a significant negative impact of obesity on prognosis, particularly in patients with acute lymphoblastic leukemia and brain tumors.
A new study found significant disparities in the use of obesity-management medications among different racial and ethnic groups. People of Asian, Black, and Hispanic descent were significantly less likely to use these medications compared to whites, even after adjusting for income, education, health insurance coverage, and clinical need.
A recent clinical study confirms kimchi's ability to reduce body fat and improve gut health, with a notable 31.8% reduction in body fat among animal models. Additionally, human studies show a 15% reduction in BMI and 12% decrease in obesity incidence among middle-aged males.
The Lancet predicts devastating trends at the population level, with 43.1 million US children and adolescents and 213 million adults expected to have overweight or obesity by 2050. Without significant reform, the prevalence of overweight and obesity is set to continue and even increase in some states.
A nationwide study in Japan reveals an increasing trend of overweight and obesity among patients with incident end-stage kidney disease (ESKD), mirroring the global obesity epidemic. Underweight individuals remain prevalent, presenting a dual challenge for public health strategies.
A new NIH study found exposure to organophosphate esters (OPEs) during pregnancy may affect childhood obesity risk. Children exposed to higher levels of certain OPEs had a greater or lower risk of obesity compared to those with lower exposure.
A Johns Hopkins study found that adding digital feedback to traditional health counseling for parents improves healthy growth in young children. The study, which used text messages and a web-based dashboard, reduced obesity rates in the first two years of life.
Researchers developed an algorithm that splits obesity into 5 separate diagnostic profiles with contrasting risk of developing obesity complications. This can help clinicians identify individuals who need early interventions, improving disease prediction and treatment.
A systematic review and meta-analysis found that weight-loss surgery reduces pancreatic cancer risk among individuals with obesity by 44%, and among those with both obesity and type 2 diabetes by 79%. The study suggests that metabolic-bariatric surgery may play a crucial role in reducing the risk of pancreatic cancer.
A team of scientists from NTU Singapore and HKU found that electro-acupuncture can reverse the effects of obesity in obese individuals and mice on a high fat diet. The treatment targets osteoprotegerin, a protein linked to fat cell formation and obesity development.
A recent study published in Liver Cancer found that patients with diabetes mellitus and comorbid obesity are at a higher risk of liver cancer recurrence after resection. The risk is significantly higher for those with comorbid obesity, increasing by approximately 3.8 times over five years postoperatively.
A new study suggests that individuals struggling with obesity face varying levels of social and health difficulties depending on where they live. Researchers found that those living in areas with high obesity rates report fewer relationship, economic, and health disadvantages compared to those in low-obesity regions.